Tag: Biotech
Inflarx’s Covid drug approved in the US – stock rises sharply
Niels Riedemann The founder and CEO of Inflarx sees hope in the drug for seriously ill Covid patients. (Photo: InflaRx) Frankfurt An approval success that many investors no longer expected…
Biontech decides billion dollar deal for new cancer drugs
Biontech Just two weeks after the multi-million dollar deal with the US cancer specialist OncoC4, the Mainz-based company agreed on another partnership. (Photo: dpa) Frankfurt Biontech is stepping on the…
Biontech is setting itself apart from the rest of the industry more and more
Frankfurt The success of Mainz-based Biontech SE in Covid vaccine development has put the German biotech industry in the spotlight. However, hopes that the rise of the mRNA and oncology…
Covid sales will fall sharply, continued focus on research
Frankfurt After two record years, Mainz-based Biontech SE is heading for significantly lower revenues in the Covid vaccine business. Irrespective of this, the biotech company intends to continue to massively…
Covid sales will fall sharply, continued focus on research
Frankfurt After two record years, Mainz-based Biontech SE is heading for significantly lower revenues in the Covid vaccine business. Irrespective of this, the biotech company intends to continue to massively…
Biontech secures new cancer drug with deal worth millions
Biontech founder Ugur Sahin The company is currently also growing through acquisitions. (Photo: imago images/photothek) Frankfurt With one of its largest deals to date, Biontech is expanding its product development…
Biotech has to adjust to a dry spell in terms of financing
DNA experiment In view of the declining inflow of capital, rapid successes are required in research. (Photo: imago images/Westend61) Frankfurt The collapse of the Silicon Valley Bank (SVB) and the…
Pfizer acquires cancer specialist Seagen for $43 billion
Pfizer logo The US pharmaceutical company takes over the cancer specialist Seagen for 43 billion dollars. (Photo: AP) Frankfurt The US group Pfizer is using its billions in revenue from…
Pfizer acquires cancer specialist Seagen for $43 billion
Pfizer The US pharmaceutical company takes over the cancer specialist Seagen for 43 billion dollars. (Photo: Bloomberg via Getty Images) Frankfurt The US pharmaceutical company Pfizer is planning one of…
A biotech expert for Bayer: That’s how Bill Anderson ticks
Bill Anderson The former Roche pharmaceutical boss will become the new CEO of Bayer. (Photo: dpa) Zurich, Dusseldorf “I couldn’t be happier to join Team Bayer.” That was the first…
A biotech expert for Bayer: That’s how Bill Anderson ticks
Bill Anderson The former Roche pharmaceutical boss will become the new CEO of Bayer. (Photo: dpa) Zurich, Dusseldorf “I couldn’t be happier to be joining Team Bayer.” That was the…
US investors rely on German biotech companies
New York, Boston Caroll Neubauer has no doubt: “Germany is currently very interesting,” says the chief adviser to the US investment company Waterstreet, who is looking for investment opportunities in…
This is how the USA wants to defeat cancer
Bayer research on cell cultures The group invests in modern cell and gene therapies. (Photo: Bayer AG) Boston, NY Joe Biden accelerates the fight against cancer. On Thursday, the White…
Undercover biotech star expands into cell therapy
Frankfurt Novel cell and gene therapies have been causing a sensation in medicine for several years. German pharmaceutical companies do not yet play a major role here. But a biotech…
Undercover biotech star expands into cell therapy
Frankfurt Novel cell and gene therapies have been causing a sensation in medicine for several years. German pharmaceutical companies do not yet play a major role here. But a biotech…
Biotech companies will raise less capital in 2022
Frankfurt After record figures in the first two years of the corona pandemic, German biotech companies raised significantly less capital in 2022. A total of 921 million euros in fresh…
Biontech and Moderna in the expansion race
Frankfurt Your sales in the Covid business will fall significantly in the current year. In research, however, Moderna and Biontech are continuing to expand at high speed. This was made…
Curevac takes Sanofi manager Alexander Zehnder as boss – share increases
Alexander Zehnder The experienced pharmaceutical manager will become the new CEO of Curevac. (Photo: Curevac) Frankfurt After an intensive search in recent weeks, the biotech company Curevac has now found…
Curevac takes Sanofi manager Alexander Zehnder as boss – share increases
Curevac headquarters in Tübingen After the flop with the vaccine, the company is realigning itself. (Photo: imago images/ULMER press photo agency) Frankfurt After an intensive search in recent weeks, the…
Curevac is trying to restart staff
Curevac boss Franz-Werner Haas in August 2020 on the video facade of the Nasdaq in Times Square The company’s share price has plummeted since its IPO. (Photo: dpa) Frankfurt At…